Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Schroder Uk Public Private Trust Plc LSE:SUPP London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 35.00 5,000 08:25:09
Bid Price Offer Price High Price Low Price Open Price
34.05 34.80
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments -5.07 -0.56 318
Last Trade Time Trade Type Trade Size Trade Price Currency
08:00:50 O 5,000 34.458 GBX

Schroder Uk Public Private (SUPP) Latest News

More Schroder Uk Public Private News
Schroder Uk Public Private Investors    Schroder Uk Public Private Takeover Rumours

Schroder Uk Public Private (SUPP) Discussions and Chat

Schroder Uk Public Private Forums and Chat

Date Time Title Posts
07/5/202108:18Schroder UK Public Private 280
05/5/202113:32::: SCHRODER UK PUBLIC PRIVATE TRUST :::942
20/12/201922:36SUPP2
18/2/200409:0824 Hour clock1

Add a New Thread

Schroder Uk Public Private (SUPP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:00:5234.465,0001,722.90O
2021-05-06 15:35:1135.001,636572.60UT
2021-05-06 15:17:0534.401,512520.13O
2021-05-06 15:14:3534.662,639914.71O
2021-05-06 15:00:2034.955,7692,016.27AT
View all Schroder Uk Public Private trades in real-time

Schroder Uk Public Private (SUPP) Top Chat Posts

DateSubject
06/5/2021
09:20
Schroder Uk Public Private Daily Update: Schroder Uk Public Private Trust Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker SUPP. The last closing price for Schroder Uk Public Private was 35p.
Schroder Uk Public Private Trust Plc has a 4 week average price of 30.60p and a 12 week average price of 30.60p.
The 1 year high share price is 39.85p while the 1 year low share price is currently 21.10p.
There are currently 908,639,238 shares in issue and the average daily traded volume is 1,275,076 shares. The market capitalisation of Schroder Uk Public Private Trust Plc is £318,023,733.30.
28/4/2021
22:43
chucko1: Isn't IPO 25% exposed to ON and SUPP only about 4%? I have not seen the Stocko stuff (in fact, I have not the least idea what it is), but if I am correct then you would have to buy 6.25x as much SUPP to get the same actual exposure to IPO. Whether or not SUPP is "cheap" however so defined, the risk in having to buy 6.25x as much can hardly be ignored. For it means you are buying 6.25x as much IH as a sane person would wish. And 6.25x as much Atom, with the funding requirements involved there also. Where the calculation becomes more complex is when taking into consideration the respective current valuations of ON within the portfolios of SUPP and IPO, and that is not that clear. This is where Stocko might have a better idea than me, but to use this calculation properly would require a clear view of where ON would be priced. The valuation difference would have to be immense (it is not) to offset the risk of having go buy 6.25x SUPP. Either that or you are very confident that the discount SUPP currently trades at will narrow, in which case whatever happens to ON is barely relevant if it only amounts to 4% of the NAV. I would love to be shown to be incorrect, but until someone presents the analysis here I suspect "clueless" is still apt for the majority of SUPP acolytes.
28/4/2021
20:06
chucko1: The point about investing via IPO is that you did not expose yourself to the very likely further markdowns in the NAV of the other stuff (in SUPP). So, the idea that you get better (lower price) like-for-like exposure via SUPP is missing the point. As has been shown the past year (IPO up 200% or so and SUPP up 50% or so). They might have said precisely the same thing then. But what of the future? Closer call now but only because of the further write-down suffered by SUPP (basically another 12% taken from the share price). If they have IH valued still at anything other than nominal, then you can add to the troubles. And what of the future funding requirements? Why bother with the baggage?
09/4/2021
08:57
spectoacc: @zimmie - a brave call to suggest more coming over the next 12 months. Yes, they've bounced from Covid lows - underperforming the FTSE - but still a bounce, & I was fortunate to sell out what I'd bought at under 30p before this week's NAV fiasco, as posted at the time. ON may float - perhaps 5p on the NAV, more if lucky. But that return isn't coming back to shareholders - it's going into new punts, they've said as much. "Schroders Juniors" because it's a pair of untested kids - now also running SBO, but still taking the same fees out of SUPP. SBO is a mess of tiny stakes, and I think they'll do the same with any SUPP cash. In which case, your "Patient" of the past 6 years extends out for how long? When do you ever expect to see a return, of any kind? What have Schroders achieved in over a year. Buying the Kymab that WEIF were dumping was a big plus. But selling a decent set of holdings at a 22% discount to Link's already marked-down NAV was poor. Now they want you to trust them to invest SUPP's ON cash. I'd be delighted to research the "..ON and other Kymab's.." you mention. I see a NAV still not kitchen-sinked, and an share price trading far too near to it, even adding 5p for ON. But good luck to holders, something may turn up?
08/4/2021
17:56
chucko1: Always useful to keep up with the times: last 12 months: SUPP + 30% (precisely) FTSE + 36% (including dividends) IPO + 160% But let's look at the 100 day volatilities: SUPP 50% FTSE 15% IPO 35% (source: BBG GP, HVG functions and some mental arithmetic) So, risk adjusted, buying or even holding SUPP is for total morons, or those unable to stomach the realisation of deep losses (they ought to have taken moderate losses at 78p when the game was clearly up). Quite a curt analysis, but I cannot be bothered to expend a lot of time on what should be obvious - SUPP is a disaster in plain sight. Even more so after the "disappointing" results announced yesterday. Current holders are being taken for fools - which they clearly are ["they are" relating to both "being taken" and being described as "fools"]. Furthermore, Schroders's reputation is under pressure here. But it was more than likely that £3mn per annum would blind the "kids" to the longer term consequences of taking on this financial sewage. Were I running the fund, I would simply be acting in a manner such as to minimise the losses. It's a laugh a day is SUPP.
08/4/2021
07:38
spectoacc: Lol @bisiboy - fair point. Have to ask the q for the umpteenth time - because I've never got an answer - when on earth do SUPP shareholders ever expect to see a return? Floated in 2015 at 100p, raised more cash above that, NAV now 35p (40p if generous, but ON yet to definitely float). Schroders happy to rip c.£3m/year out and going to start punting on their own early-stage picks, with no previous record. There's patient, then there's Patient. Isn't that Greater Fool Theory isn't a valid investment style - it's that there's quite so many greater fools where SUPP is concerned. For the avoidance of doubt - the NAV still hasn't been kitchen-sinked. It's still a Not Asset Value, albeit one finally getting there, having been walked down to here from the early 80p's over several years. None of this is rocket science. When ATOM last year said they needed £100m more, could raise it easily, and would do so in 1st qtr 2021, it should have raised alarm bells when they raised half that late in the qtr, and at half the then valuation. When RUTH get the benefit of the NHS pandemic deal, getting their costs paid, and still can't turn a profit, and still need to raise cash against property, that should ring claxons. When ON have the chance of a Cazoo-style blockbuster SPAC listing, yet announce "maybe 2nd half of year, in UK", and Schroders say they'll punt any cash they get from it, more bells. [Cazoo have sold all of 20,000 cars, and valued in US at $7bn). I could go on. But will leave with a reminder of the large IH write-up in 2018, that had many of us tearing our hair out at the time: "Shares in WPCT jumped 4.4p to 86p, a high for this year, after Link Fund Solutions, the trust’s appointed alternative investment fund managers, dramatically upgraded the value of Industrial Heat by 357% to $112.9 million (£85.2 million). Although the trust’s share price remains well below its 100p launch three years ago, the hike in Industrial Heat’s valuation boosts its underlying net asset value (NAV) by 8.8% with NAV per share rising 8.02p to 99.6p, broadly back at the level it floated at in 2015."
12/1/2021
13:53
spectoacc: @Sky - I'm cynical of SUPP, as I was of WPCT, which I called from above 80p to below 20p (where it went in March). SUPP is a mish-mash of mainly legacy cr*p, which is now paying some young guns from Schroders to run it (at least Neil was free - ish). But the existential threat of the OD getting called in in a year's time should be gone with the Kymab deal. What's the rest worth? Not Link's NAV, you'd only need to look at eg IH still being in. But in some ways, what it's worth doesn't matter, if there's people buying and some tosher tipping it. If it's going up - I believe it is - happy to be long, regardless of the underlying. (ON, the one really good one, should hopefully float this year. I'll be out in the spike ahead of it). Bear points - SUPP is only really ON, RUTH, and ATOM. Benevolent a further 8%. Everything else is small (Kymab proceeds will mostly go against OD). And whilst ON is good, RUTH needs money & isn't investable IMO; ATOM needs £100m this qtr, which I'm sure it'll get, but not without dilution to SUPP. Benevolent is at least supported by Temasek, albeit at half the original SUPP valuation. Repeating myself, but SUPP is cr*p that I want to be long of when I believe it's going up. You'll also know I'm a realist if not outright cynical on most of what I hold ;)
04/1/2021
10:13
spectoacc: Got the impression from RUTH that they may raise via debt rather than equity, but ATOM needs £100m before April, and SUPP will be supplying none of that & getting diluted. ATOM at least have other large investors, and maybe that will stop dilution being too great - tho if they're crafty, they'll do it via loan notes & extract value that way. Considering SUPP is basically RUTH, ON, ATOM, and a long tail of mainly dross, there's only really ON to pay off the c.£100m OD. (Benevolent supported by Temasek and is 8% of SUPP; Immunocore 6%, but then quickly into the 3% & below holdings). I still think it'll go mid-30's tho - not based on SUPP holders ever seeing any money back, but based on Greater Fool Theory, CLIG going to a suspicious 10% (EGM level), and that other stakebuilder. As well as even just rumours of the ON float. Worth remembering that SUPP previously sold down some of ON in a funding round, and assume they'd sell the lot given a good opportunity. As said above, even with a blockbuster ON flotation that pays the OD down to zero, you're left with a mighty iffy and even more concentrated portfolio. Just don't see how the Schroders boys can achieve their "completely different" holdings by Q4 this year. Credit to them if they do, but - they won't ;)
24/11/2020
15:06
pete_bane: I'm expecting to hear from chuckowinnie, or specto, or jonwig any minute. They check the SUPP share price every 15-20 minutes and they post to crow if it ever goes lower by .3 of a penny. Still a long way from 0p, though, which all three predicted (and topvest) LOL. I'm having a basalt fibre cake for Christmas.
19/11/2020
10:03
chucko1: Thought of the day: market cap of SUPP is £250mn at a share price of 27.515p. [now 26.35p]. SUPP has fallen from 28-29p recently - you don't think SUPP investors are throwing in the towel and being encouraged to support the new fund!! (not really a question, but if SUPP cannot rally in the current market conditions, or in the tech run-up of the past year, the longer term prospects are hardly a fountain of optimism).
26/10/2020
08:39
spectoacc: I'm convinced they want the "Schroders British Opportunities Trust" to co-invest, perhaps even buy, some of the SUPP holdings. SUPP have no money (negative money) to "support" even those that might show some promise - eg Inivata. Some are getting by raising from other investors, but whilst those likely survive, the SUPP holding gets smaller with dilution. Not helped by SUPP needing to sell down when there's sufficient liquidity (eg ON sales - interesting to see if they sold any more the other week). OD still over £100m, few obvious avenues to reduce it beyond selling the last of the listed Autolus, the last of ON (a float would be a boon, but SUPP hardly calling the shots). RUTH is at least taxpayer-supported for time being, but ATOM needs more cash and soon. Benevolent got Temasek on board but the valuation wasn't pleasant for SUPP, and won't be next time either - Temasek owe SUPP nothing. SUPP from a few weeks ago: "...The focus on adjusting position sizes towards a more balanced portfolio, whilst reducing debt, also remains front of mind and we hope to be able to provide further colour on the progress being made here soon." "Front of mind". "Colour". :) Over a year in, & Schroder Juniors have achieved next to nothing, other than raking in fees. The new IT would share a co-manager, so interesting to see how they'd managed the conflicts of interest - screw SUPP, or screw the new investors? But still - it's an avenue for something to happen, and something they'd have control of. A few "invested at NAV" deals might make SUPP holders think there's really 45p of value in there.
Schroder Uk Public Private share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
SUPP
Schroder U..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210507 07:44:32